321 related articles for article (PubMed ID: 35162068)
1. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
[TBL] [Abstract][Full Text] [Related]
2. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
[TBL] [Abstract][Full Text] [Related]
3. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.
Al-Shouli ST; Meo SA; Alafaleq NO; Sumaily KM; Alshehri A; Almutairi A; Eidalsharif A; Alsulami F; Alhanaya S
Viruses; 2023 May; 15(6):. PubMed ID: 37376577
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS
Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
Lee Y; Min P; Lee S; Kim SW
J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
[TBL] [Abstract][Full Text] [Related]
7. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
8. Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection.
Púa Torrejón RC; Ordoño Saiz MV; González Alguacil E; Furones García M; Cantarín Extremera V; Ruiz Falcó ML; Soto Insuga V
Pediatr Neurol; 2022 Nov; 136():28-33. PubMed ID: 36084419
[TBL] [Abstract][Full Text] [Related]
9. Testing for anosmia and ageusia in patients presenting to the emergency department with suspected coronavirus disease 2019 in Saudi Arabia.
Kentab OY; Ibrahim AAA; Soliman KR; Alanazi M; Alsunaid A; Ababtain A; Alresseeni AI; Algarni A; Aljohani K; Aljahany M
J Int Med Res; 2022 May; 50(5):3000605221096280. PubMed ID: 35510652
[TBL] [Abstract][Full Text] [Related]
10. Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia.
Koyama S; Kondo K; Ueha R; Kashiwadani H; Heinbockel T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445619
[TBL] [Abstract][Full Text] [Related]
11. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review.
Santos REA; da Silva MG; do Monte Silva MCB; Barbosa DAM; Gomes ALDV; Galindo LCM; da Silva Aragão R; Ferraz-Pereira KN
Am J Otolaryngol; 2021; 42(2):102889. PubMed ID: 33445036
[TBL] [Abstract][Full Text] [Related]
12. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study.
Maamar M; Artime A; Pariente E; Fierro P; Ruiz Y; Gutiérrez S; Tobalina M; Díaz-Salazar S; Ramos C; Olmos JM; Hernández JL
Curr Med Res Opin; 2022 Jun; 38(6):901-909. PubMed ID: 35166141
[TBL] [Abstract][Full Text] [Related]
14. Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media.
Koyama S; Ueha R; Kondo K
J Med Internet Res; 2021 Apr; 23(4):e26459. PubMed ID: 33788699
[TBL] [Abstract][Full Text] [Related]
15. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
[TBL] [Abstract][Full Text] [Related]
16. Assessment of anosmia/hyposmia in post-COVID-19 patients: a cross-sectional study in an eastern province of Saudi Arabia.
Mohamed R; Alsuhibani R; Almasaoud H; Alsubhi S; Alabdulazeem L; Alzahrani N; Alsaif S; Al Ghamdi K; Al-Asoom L
Acta Biomed; 2023 Dec; 94(6):e2023259. PubMed ID: 38054673
[TBL] [Abstract][Full Text] [Related]
17. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
[TBL] [Abstract][Full Text] [Related]
18. Symptom profiles and their risk factors in patients with post-COVID-19 condition: a Dutch longitudinal cohort study.
van Zon SKR; Ballering AV; Brouwer S; Rosmalen JGM;
Eur J Public Health; 2023 Dec; 33(6):1163-1170. PubMed ID: 37608757
[TBL] [Abstract][Full Text] [Related]
19. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
[No Abstract] [Full Text] [Related]
20. Loss of Taste and Smell are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study.
Farah Yusuf Mohamud M; Garad Mohamed Y; Mohamed Ali A; Ali Adam B
Infect Drug Resist; 2020; 13():2631-2635. PubMed ID: 32801800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
